Skip to main content
Premium Trial:

Request an Annual Quote

Queen's University Using Xceed Molecular's Ziplex in Follicular Lymphoma Study

NEW YORK (GenomeWeb News) – Ontario’s Queen’s University is using a gene expression analysis system from Xceed Molecular in its efforts to develop technology that will help predict clinical outcomes for follicular lymphoma patients, the company said yesterday.
Queen’s College researcher Harriet Feilotter will lead studies using Xceed’s Ziplex System to validate a gene expression signature linked to a type of this form of non-Hodgkin lymphoma. This cancer grows slowly, and it mainly affects older adults, both men and women in equal numbers.
“Currently there are no molecular diagnostic tools on the market that can predict which primary tumors will be aggressive,” Feilotter said in a statement, but having an easy way to gauge individual risk will help doctors develop beneficial treatment plans.
Xceed President and CEO David Deems said in a statement that Feilotter’s follicular lymphoma studies, which use both archival and fresh frozen tissues as source samples, show "great promise,” and have "implications far beyond this particular research study.”
Financial terms of the agreement were not released.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.